Neoadjuvant Systemic Therapy (NAST) in Patients with Melanoma: Surgical Considerations by the International Neoadjuvant Melanoma Consortium (INMC)
2022 · Annals of Surgical Oncology · 42 citations
https://doi.org/10.1245/s10434-021-11236-y
D
Dale Han
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
131
Papers
1.5K
Citations
22
h-index
40
i10-index
Dale Han is an academic researcher from Oregon Health & Science University. The author has contributed to research in topics: Cutaneous Melanoma Detection and Management & Nonmelanoma Skin Cancer Studies & Melanoma and MAPK Pathways. The author has an h-index of 22, co-authored 112 publications.
ORCID: 0000-0002-0741-2089Papers by this author
worksNonvisualization of Sentinel Lymph Nodes by Lymphoscintigraphy in Primary Cutaneous Melanoma: Incidence, Risk Factors, and a Review of Management Options
2018 · Plastic & Reconstructive Surgery · 10 citations
https://doi.org/10.1097/prs.0000000000004771
Relationship of patient age to tumor factors and outcomes among patients undergoing sentinel node biopsy for melanoma
2020 · The American Journal of Surgery · 7 citations
https://doi.org/10.1016/j.amjsurg.2020.03.013
A Clinical Decision Tool to Calculate Pretest Probability of Sentinel Lymph Node Metastasis in Primary Cutaneous Melanoma
2023 · Annals of Surgical Oncology · 7 citations
https://doi.org/10.1245/s10434-023-13220-0
STAT3β Isoform Specific Aptamer-Based Targeted Therapy for End-Stage Kidney Diseases
2025 · American Journal of Transplantation · 0 citations
https://doi.org/10.1016/j.ajt.2025.07.1905
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat